Tuesday, November 13, 2007

Hope for MS

Hope for MS
ABC 7 Chicago Mon, 12 Nov 2007 9:41 AM PST
A new treatment that could stop multiple sclerosis in its tracks! that story next, on medical breakthroughs.

Blood pressure drug hope for MS
BBC News Sun, 11 Nov 2007 5:21 PM PST
A drug for high blood pressure may turn out to be a key treatment for multiple sclerosis, say UK researchers.

Scientists Find Way to Track Stem Cells in Brain
iVillage Total Health Mon, 12 Nov 2007 3:08 AM PST
The identification of a new marker is making it possible to track brain stem cells for the first time, U.S. researchers report. The achievement is already opening doors to new research into depression, early childhood development and multiple sclerosis, the team's senior author said. "This is a way to detect these cells in the brain, so that you can track them in certain conditions where we ...

Untangling the Web
Fort Worth Star-Telegram Mon, 12 Nov 2007 1:11 AM PST
By Jan Jarvis Two new health sites www.MyMSMyWay.com What it is: Snapshot is a personal, interactive tool for those with multiple sclerosis. The Web site examines how technology can help people with MS adapt to their ever-changing needs. It offers tips, such as using text messaging or cellphone alerts to remind individuals to take their medication. Also: Something as simple as ...

Inspiring TV Documentary Explores Role Of Science In MS, UK
Medical News Today Mon, 12 Nov 2007 5:03 AM PST
Digital TV channel the Community Channel has joined together with the MS Society to explore the role of science in multiple sclerosis (MS) in an inspiring documentary. [click link for full article]

Anti-Inflammation Molecule Helps Fight MS-Like Disease
Medical News Today Mon, 12 Nov 2007 3:18 AM PST
An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D. [click link for full article]

Teva begins enrolment in phase III study of oral laquinimod
PharmaBiz Sun, 11 Nov 2007 9:41 PM PST
Teva Pharmaceutical Industries Ltd. and Active Biotech AB has announced the initiation of enrolment in the Allegro trial (assessment of oral laquinimod in preventing progression of multiple sclerosis).

Biogen auction running out of steam, some bidders walking away ...
Financial Times (subscription) - London,England,UK
The difficulty in appraising Biogen's assets and coming to an agreement with Elan and Genentech over their partnerships with Tysabri and Rituxan, ...
See all stories on this topic

An Introduction To Adult Stem Cells
By victorhof8707(victorhof8707)
For this reason, researchers such as Kursad Turksen in his book 'Adult Stem Cells' offer the following wisdom: Adult stem cell biology is at the forefront of the emerging field of regenerative medicine, offering a source of cells to ...
Victor Ho27091 - http://victorho5479.blogspot.com/

UPDATE 1-Reuters Summit-Genentech unlikely to fully buy Rituxan
Reuters - USA
The next-generation drugs, including ocrelizumab for arthritis, are so-called "humanized" antibodies that are expected to be better tolerated than Rituxan. ...
See all stories on this topic

BioMS Medical achieves enrollment milestone in US phase III ...
Canada NewsWire (press release) - Toronto,Ontario,Canada
(TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that more than 133 patients have been enrolled in its MAESTRO-03 ...
See all stories on this topic

MS victim's assisted suicide heartache
Mirror.co.uk - London,UK
Debbie, who lives in Bradford, was told she had Primary Progressive MS, a form of the disease that affects just 10 per cent of sufferers. ...
See all stories on this topic


Post a Comment

Links to this post:

Create a Link

<< Home